ATE323675T1 - Indol- und dihydroindolderivate - Google Patents

Indol- und dihydroindolderivate

Info

Publication number
ATE323675T1
ATE323675T1 AT01994697T AT01994697T ATE323675T1 AT E323675 T1 ATE323675 T1 AT E323675T1 AT 01994697 T AT01994697 T AT 01994697T AT 01994697 T AT01994697 T AT 01994697T AT E323675 T1 ATE323675 T1 AT E323675T1
Authority
AT
Austria
Prior art keywords
indole
dihydroindole derivatives
dihydroindole
derivatives
Prior art date
Application number
AT01994697T
Other languages
English (en)
Inventor
Jean Ackermann
Johannes Aebi
Henrietta Dehmlow
Olivier Morand
Narendra Panday
Thomas Weller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE323675T1 publication Critical patent/ATE323675T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT01994697T 2000-11-28 2001-11-21 Indol- und dihydroindolderivate ATE323675T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00125955 2000-11-28

Publications (1)

Publication Number Publication Date
ATE323675T1 true ATE323675T1 (de) 2006-05-15

Family

ID=8170500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01994697T ATE323675T1 (de) 2000-11-28 2001-11-21 Indol- und dihydroindolderivate

Country Status (15)

Country Link
US (1) US6503907B2 (de)
EP (1) EP1349833B1 (de)
JP (1) JP4068457B2 (de)
KR (1) KR100523888B1 (de)
CN (2) CN1733723A (de)
AR (1) AR034186A1 (de)
AT (1) ATE323675T1 (de)
AU (2) AU2002224870B2 (de)
BR (1) BR0115618A (de)
CA (1) CA2428315C (de)
DE (1) DE60118970T2 (de)
ES (1) ES2261518T3 (de)
MX (1) MXPA03004687A (de)
WO (1) WO2002044149A1 (de)
ZA (1) ZA200303689B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075931A2 (en) * 2005-12-22 2007-07-05 Biosite Incorporated Reactive heterocyclic derivatives and methods for their synthesis and use
FR2913016B1 (fr) * 2007-02-23 2009-04-24 Cerep Sa Derives d'indole, benzimidazole ou benzotriazole, comprenant un noyau piperidine ou piperazine, comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
CN106749074A (zh) * 2016-11-14 2017-05-31 沈阳药科大学 一种联芳基噁唑烷酮中间体的制备方法
TWI748194B (zh) 2018-06-28 2021-12-01 德商菲尼克斯 Ｆｘｒ有限責任公司 含有雙環核心部分之新穎lxr調節劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
JPH0764841B2 (ja) * 1990-10-03 1995-07-12 ファイザー製薬株式会社 インドール誘導体およびその用途
TW438774B (en) 1993-07-14 2001-06-07 Hoffmann La Roche Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines
AU1608397A (en) * 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
EP0801060A1 (de) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclische Beta-3 adrenergische Angonisten
US5958965A (en) * 1996-08-27 1999-09-28 American Home Products Corporation 4-aminoethoxy indoles
GB9919411D0 (en) * 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1349833A1 (de) 2003-10-08
CA2428315A1 (en) 2002-06-06
ES2261518T3 (es) 2006-11-16
WO2002044149A1 (en) 2002-06-06
CN1245385C (zh) 2006-03-15
DE60118970T2 (de) 2007-04-12
CN1476432A (zh) 2004-02-18
AR034186A1 (es) 2004-02-04
CA2428315C (en) 2009-02-17
CN1733723A (zh) 2006-02-15
AU2487002A (en) 2002-06-11
AU2002224870B2 (en) 2007-06-21
MXPA03004687A (es) 2003-09-05
JP2004520291A (ja) 2004-07-08
US20020103247A1 (en) 2002-08-01
KR100523888B1 (ko) 2005-10-26
US6503907B2 (en) 2003-01-07
ZA200303689B (en) 2004-08-13
DE60118970D1 (de) 2006-05-24
JP4068457B2 (ja) 2008-03-26
EP1349833B1 (de) 2006-04-19
KR20030051880A (ko) 2003-06-25
BR0115618A (pt) 2003-09-16

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1233943T3 (da) Ioniserbare indolinon derivater og anvendelse deraf som PTK ligander
NO20014096D0 (no) Fenyl- og pyridinylderivater
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
CY2016002I2 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20013809D0 (no) Indolderivater og anvendelse derav som MCP-1 antagonister
ATE540013T1 (de) Naphthalinderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20023770L (no) Indol-3-ylderivater
IS6594A (is) 2-asýl indól afleiður og notkun þeirra sem miðla gegn æxlum
AU8664701A (en) Oxindole derivatives
ATE257148T1 (de) Propargyletherderivate
NO20004277L (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
DK1153014T3 (da) Beta-alaninderivater
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
ATE299876T1 (de) Indolderivate
IS2607B (is) Afleiður tryptamíns og hliðstæð efnasambönd ásamt lyfjaforskriftum þeirra
IS6434A (is) Nýjar indól afleiður
DK1228041T3 (da) Indolderivater og anvendelse deraf som SHT2A-ligander
ATE317386T1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20001718D0 (no) Benzen-fusjonerte heterocykliske derivater og anvendelse derav
ATE323675T1 (de) Indol- und dihydroindolderivate
DK1305307T3 (da) Indolderivater
DK1214312T3 (da) 5-aminoalkyl- og 5-aminocarbonylsubstituerede indoler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349833

Country of ref document: EP

REN Ceased due to non-payment of the annual fee